Regulatory & Legal
BSE India8 Sept 2026, 5:30 am IST
Sun Pharma receives credit ratings from Moody's and S&P
What happened
- Moody’s has assigned a Baa1 rating and S&P has assigned a BBB+ rating to Sun Pharma.
- Both ratings are stable and reflect the company's acquisition of Organon.
Key terms explained
Financial terms from this story, in everyday words.
- Credit Rating
- An assessment of a company's ability to pay back its debts.
Original source
BSE India
Was this summary clear?
For information only — not investment advice.Summarized automatically; always check the original before acting.